High incidence of post transplant lymphoproliferative disorder after antithymocyte globulin-based conditioning and ineffective prediction by day 28 EBV-specific T lymphocyte counts

Mette Hoegh-Petersen(Alberta Health Services), Jan Storek(Oklahoma State University Medical Center), Dawn Goodyear(Alberta Health Services), Andrew Daly, K Fonseca(University of Calgary), S Liu(Alberta Health Services), Peter Duggan(Alberta Health Services), Michelle Geddes(Alberta Health Services), Jeffrey A. Russell(Alberta Health Services), John T. Walker(Western University), Doug Stewart(Alberta Health Services), Alejandra Ugarte-Torres(Alberta Health Services)
Bone Marrow Transplantation
November 8, 2010
10.1038/bmt.2010.272
Cited by 40

Related Papers

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
|New England Journal of Medicine|2018|584
CD34 cell dose in granulocyte colony-stimulating factor–mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen–identical sibling transplantation
|Blood|2001|227
Concise Review: Wharton's Jelly: The Rich, but Enigmatic, Source of Mesenchymal Stromal Cells
|Stem Cells Translational Medicine|2017|210
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission
|Blood Advances|2019|128
Periostin as a multifunctional modulator of the wound healing response
|Cell and Tissue Research|2016|125